WASHINGTON — The Heart Rhythm Society (HRS) is aware of the ongoing Department of Justice (DOJ) civil investigation of Implantable Cardioverter Defibrillator (ICD) implants and has agreed to assist in an advisory role to lend expertise concerning proper guidelines for clinical decision making. HRS is reviewing information that does not include either identifiable patient or facility level data.
Search for "" returned 177 matches
WASHINGTON, December 8, 2010 — The outcome of a recent expert consensus workshop, "NHLBI/HRS Workshop on Prediction and Prevention of Sudden Cardiac Death," identifies knowledge gaps and offers six specific research recommendations in high priority areas for sudden cardiac death (SCD) prediction and prevention. In the In the United States, SCD continues to claim more than 250,000 lives annually and is the cause of half of all heart disease deaths. The special report, Sudden Cardiac Death (SCD) Prediction and Prevention: Report from a National Heart, Lung and Blood Institute (NHLBI) and Heart Rhythm Society Workshop, was published in the November 30th issue of Circulation, an official journal of the American Heart Association.
WASHINGTON, December 13, 2010 – The Heart Rhythm Society, the international leader in science, education and advocacy for heart rhythm professionals and patients, has received notification that the Society’s request for a physician specialty code for cardiac electrophysiology has been approved by the Centers for Medicaid and Medicare Services (CMS).
Dallas, December 20, 2010 — Strictly controlling the heart rate of patients with atrial fibrillation provides no advantage over more lenient heart rate control, experts report in a focused update of the 2006 guidelines for the management of patients with atrial fibrillation.
A new study shows that atrial fibrillation (AF) increases the risk of dementia in older adults who have not had a stroke and have normal baseline cognitive function. The meta-analysis, published in the November edition of HeartRhythm,the official journal of the Heart Rhythm Society, is the first-of-its-kind to observe a large population of patients over a relatively long follow-up period. The study results support an independent longitudinal relationship between the two conditions, therefore associating the presence of AF with greater risk of developing dementia.
Late-Breaking Clinical Trials will be revealed at Heart Rhythm 2015, the Heart Rhythm Society’s 36th Annual Scientific Sessions.
The first patient tests of a new leadless pacemaker show that the device can deliver the same life-saving therapy as a traditional single-chamber pacemaker without potential lead-related complications. The findings are part of the LEADLESS trial and were released today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.
A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care. The new findings were released today at Heart Rhythm 2013,the Heart Rhythm Society’s 34th Annual Scientific Sessions.
The Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA) and Asia Pacific Heart Rhythm Society (APHRS), release the HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. The expert consensus statement presented today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions, provides the first comprehensive statement of recommendations on the proper diagnosis and management of patients with inherited primary arrhythmia syndromes.
Hugh Calkins, MD, FHRS, CCDS, was named the president of the Heart Rhythm Society (HRS) during the 34th Annual Scientific Sessions, held in Denver last week. Announced during the Presidents’ Reception on Friday, May 10th, Dr. Calkins now serves as the 35th president of HRS, making Anne M. Gillis, MD, FHRS, the immediate past president. Dr. Calkins is currently a Nicholas J. Fortuin Professor of Medicine and Professor of Cardiology at the Johns Hopkins University of Medicine in Baltimore, Maryland.